Searched for
MEDREICH
Corner offices vacant in pharma industryMeiji Holdings of Japan, which closed the $290-million acquisition of domestic company Medreich this year, is scouting for a person to head...- Government clears 25 FDI proposals worth Rs 1,546 croreThese MBRT proposals relate to investment in setting up shop in duty free area and selling products on board on international flights, the ...
- CCI clears Temasek's 10.16% stake buy in Intas PharmaceuticalsTemasek Holding's proposed 10.16% stake purchase in Indian firm Intas Pharmaceuticals has got the approval of the Competition Commission.
- Encouraged by PM Modi's victory, Japanese infra & consumer companies step up pace in IndiaJapanese firms that are already here are intensifying their India presence, raising investments, widening product portfolios and setting am...
- Japan’s Meiji Holdings acquires Medreich for Rs 1,720 crore“The Meiji Group wants to enter the global generics field, particularly in Asia and emerging countries,” said the company press release.
- Japan's Meiji acquires Bangalore-based Medreich for $290 millionThe acquisition is through the operating subsidiaries, Meiji Seika Pharma Co Ltd, the company said in a filing to the Tokyo Stock Exchange.
- ChrysCapital to sell 10% in drug maker Intas Pharmaceuticals to Temasek for over $160 millionTemasek has bought 12.5% stake in Intas Pharmaceuticals, one of India's top 10 drug makers by sale, for a little over Rs 1,100 crore, peopl...
- DIPP to send proposal to PMO on review of pharma FDI policyThe DIPP will soon send a comprehensive proposal to the PMO for review of the current policy for FDI in existing drug companies.
- Finance ministry asked not to clear pharma FDI proposalsThe move threatens to bring foreign direct investment into the sector to a standstill that had only begun to see activity after PM himself ...
- DIPP wants relook of FDI policy in pharma at PM levelWith no let up in multinationals seeking nod to acquire stake in Indian pharma firms despite government putting norms to check it.
- FDI in pharma sector faces fresh headwinds with DIPPDepartment of Industrial Policy and Promotion seeks review of the policy barely months after it was cleared at the intervention of the PM.
- South Africa-based Adcock Ingram buys Cosme Farma for Rs 480 croreSouth Africa-based drug maker Adcock Ingram has quietly acquired privately-held Cosme Farma for Rs 480 crore, a 13 times premium over Cosme...
- Adcock's plan to buy Medpro hits Cipla hurdleSouth African company Adcock Ingram's plans to buy Cipla Medpro, with whom Cipla has a 20-year drug-supply agreement, has run into trouble ...
- India remains an attractive investment destination:TemasekSingapore-based investment firm Temasek Holdings on Wednesday said that India remains an attractive investment destination, given its robus...
Load More
